Science Explorer Back to mapMap
Discussion
Company · Incheon · South Korea

Celltrion (South Korea)

celltrion.comROR OpenAlex
Research works
103
◆ 0% vs 2018-21
Citations
1.5k
15.1 per fractional work
Top-10% rate
12.0%
all institutions 10.0%
Open access
53%
world 40%
International
42%
world 18%
Celltrion (South Korea)

Not ranked overall: Celltrion (South Korea) is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Celltrion (South Korea) work in?

In 2022-now, 40% of research at Celltrion (South Korea) is in Health Sciences, 39% in Life Sciences. Its largest fields are Medicine (39%), Immunology and Microbiology (24%), Economics, Econometrics and Finance (18%). It does 2.2× the world's share of Life Sciences.

Health Sciences: 15 fractional works · 40.1% of its workMedicine: 15 fractional works · 38.7% of its workRadiology, Nuclear Medicine and Imaging: 3 fractional works · 9.1% of its workOncology: 3 fractional works · 6.9% of its workRheumatology: 2 fractional works · 5.5% of its workPulmonary and Respiratory Medicine: 1 fractional works · 3.6% of its workEpidemiology: 1 fractional works · 2.8% of its workPediatrics, Perinatology and Child Health: 1 fractional works · 2.2% of its workInfectious Diseases: 1 fractional works · 1.9% of its workSurgery: 0 fractional works · 1.0% of its workHematology: 0 fractional works · 0.7% of its workPharmacology: 0 fractional works · 0.7% of its workPathology and Forensic Medicine: 0 fractional works · 0.6% of its workGenetics: 0 fractional works · 0.6% of its workDermatology: 0 fractional works · 0.6% of its workImmunology and Allergy: 0 fractional works · 0.4% of its workGastroenterology: 0 fractional works · 0.4% of its workNeurology: 0 fractional works · 0.4% of its workPublic Health, Environmental and Occupational Health: 0 fractional works · 0.3% of its workComplementary and alternative medicine: 0 fractional works · 0.3% of its workEndocrinology, Diabetes and Metabolism: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.4% of its workVeterinary: 0 fractional works · 1.3% of its workSmall Animals: 0 fractional works · 1.3% of its workHealth Professions: 0 fractional works · 0.1% of its workLife Sciences: 15 fractional works · 38.8% of its workImmunology and Microbiology: 9 fractional works · 24.0% of its workImmunology: 9 fractional works · 24.0% of its workBiochemistry, Genetics and Molecular Biology: 4 fractional works · 11.0% of its workGenetics: 2 fractional works · 5.4% of its workMolecular Biology: 2 fractional works · 4.3% of its workBiotechnology: 0 fractional works · 0.7% of its workCell Biology: 0 fractional works · 0.4% of its workCancer Research: 0 fractional works · 0.2% of its workAgricultural and Biological Sciences: 1 fractional works · 2.6% of its workPlant Science: 1 fractional works · 1.4% of its workAquatic Science: 0 fractional works · 0.3% of its workFood Science: 0 fractional works · 0.3% of its workAgronomy and Crop Science: 0 fractional works · 0.3% of its workAnimal Science and Zoology: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.0% of its workPharmacology, Toxicology and Pharmaceutics: 0 fractional works · 0.8% of its workPharmacology: 0 fractional works · 0.5% of its workSmaller subfields together: 0 fractional works · 0.2% of its workNeuroscience: 0 fractional works · 0.3% of its workSocial Sciences: 7 fractional works · 19.0% of its workEconomics, Econometrics and Finance: 7 fractional works · 17.9% of its workEconomics and Econometrics: 7 fractional works · 17.8% of its workSmaller subfields together: 0 fractional works · 0.2% of its workSocial Sciences: 0 fractional works · 0.9% of its workUrban Studies: 0 fractional works · 0.9% of its workPsychology: 0 fractional works · 0.1% of its workBusiness, Management and Accounting: 0 fractional works · 0.0% of its workPhysical Sciences: 1 fractional works · 2.2% of its workMathematics: 1 fractional works · 1.6% of its workStatistics and Probability: 1 fractional works · 1.6% of its workEngineering: 0 fractional works · 0.3% of its workBiomedical Engineering: 0 fractional works · 0.3% of its workChemistry: 0 fractional works · 0.3% of its workAnalytical Chemistry: 0 fractional works · 0.3% of its workALL ITS WORKCelltrion (SouthKorea)38fractional works, 2022-now
Life Sciences39%Physical Sciences2%Health Sciences40%Social Sciences19%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in 2022-now. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 15 fields, with their numbers
    1. Medicine1538.7%
    2. Veterinary01.3%
    3. Health Professions00.1%
    1. Immunology and Microbiology924.0%
    2. Biochemistry, Genetics and Molecular Biology411.0%
    3. Agricultural and Biological Sciences12.6%
    4. Pharmacology, Toxicology and Pharmaceutics00.8%
    5. Neuroscience00.3%
    1. Economics, Econometrics and Finance717.9%
    2. Social Sciences00.9%
    3. Psychology00.1%
    4. Business, Management and Accounting00.0%
    1. Mathematics11.6%
    2. Engineering00.3%
    3. Chemistry00.3%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.55× its world share, 1 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 2.07× its world share, 4 worksBiochemistry, Geneti…Immunology and Microbiology: 23.86× its world share, 9 worksImmunology and Micro…Neuroscience: 0.18× its world share, 0 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 2.24× its world share, 0 worksPharmacology, Toxico…Chemistry: 0.18× its world share, 0 worksChemistryEngineering: 0.02× its world share, 0 worksEngineeringMathematics: 1.36× its world share, 1 worksMathematicsHealth Professions: 0.03× its world share, 0 worksHealth ProfessionsMedicine: 2.01× its world share, 15 worksMedicineVeterinary: 9.60× its world share, 0 worksVeterinaryBusiness, Management and Accounting: 0.01× its world share, 0 worksBusiness, Management…Economics, Econometrics and Finance: 8.38× its world share, 7 worksEconomics, Econometr…Psychology: 0.04× its world share, 0 worksPsychologySocial Sciences: 0.07× its world share, 0 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 23.9×. Every wedge is a field page.

All 15 fields, with their numbers
  1. Immunology and Microbiology23.86×9 works
  2. Veterinary9.60×0 works
  3. Economics, Econometrics and Finance8.38×7 works
  4. Pharmacology, Toxicology and Pharmaceutics2.24×0 works
  5. Biochemistry, Genetics and Molecular Biology2.07×4 works
  6. Medicine2.01×15 works
  7. Mathematics1.36×1 works
  8. Agricultural and Biological Sciences0.55×1 works
  9. Neuroscience0.18×0 works
  10. Chemistry0.18×0 works
  11. Social Sciences0.07×0 works
  12. Psychology0.04×0 works
  13. Health Professions0.03×0 works
  14. Engineering0.02×0 works
  15. Business, Management and Accounting0.01×0 works

Who are the top researchers at Celltrion (South Korea)?

Ranked on the quality score, Sang Joon Lee, Jee Hye Suh and Jin Soo Bae lead among researchers whose main affiliation is Celltrion (South Korea).

  1. 1 Sang Joon Lee South Korea · #398,867 worldwide 3.5k citations · 68 works
  2. 2 Jee Hye Suh South Korea · #725,159 worldwide 524 citations · 29 works
  3. 3 Jin Soo Bae South Korea · #1,208,435 worldwide 1.2k citations · 20 works
  4. 4 Yunju Bae South Korea · #1,436,348 worldwide 459 citations · 30 works
  5. 5 Keum Young Ahn South Korea · #1,554,360 worldwide 597 citations · 16 works
  6. 6 Ji-Min Seo South Korea · #1,559,496 worldwide 584 citations · 17 works
  7. 7 Dong-Kyun Ryu South Korea · #1,975,513 worldwide 704 citations · 17 works
  8. 8 Mi Rim Kim South Korea · #2,096,207 worldwide 342 citations · 19 works
  9. 9 Jakub Trefler South Korea · #2,223,374 worldwide 369 citations · 34 works
  10. 10 D H Kim South Korea · #2,305,016 worldwide 14 citations · 16 works
All ranked researchers at Celltrion (South Korea)

What are the most cited papers from Celltrion (South Korea)?

The most cited paper from Celltrion (South Korea) is "A randomised, double-blind, parallel-group study to demonstrate equivalence in efficacy and safety of CT-P13 compared with innovator infliximab when coadministered with methotrexate in patients with active rheumatoid arthritis: the PLANETRA study" (Dae‐Hyun Yoo, Paweł Hrycaj, Pedro Cavaleiro Miranda et al., 2013), with 655 citations. Next come "A randomised, double-blind, multicentre, parallel-group, prospective study comparing the pharmacokinetics, safety, and efficacy of CT-P13 and innovator infliximab in patients with ankylosing spondylitis: the PLANETAS study" (607) and "Defining variant-resistant epitopes targeted by SARS-CoV-2 antibodies: A global consortium study" (343).

Most cited papers
#PaperReleasedCitations
1 A randomised, double-blind, parallel-group study to demonstrate equivalence in efficacy and safety of CT-P13 compared with innovator infliximab when coadministered with methotrexate in patients with active rheumatoid arthritis: the PLANETRA study Dae‐Hyun Yoo, Paweł Hrycaj, Pedro Cavaleiro Miranda et al. · Annals of the Rheumatic Diseases Open access 18 May 2013 655
2 A randomised, double-blind, multicentre, parallel-group, prospective study comparing the pharmacokinetics, safety, and efficacy of CT-P13 and innovator infliximab in patients with ankylosing spondylitis: the PLANETAS study Won Park, Paweł Hrycaj, Sławomir Jeka et al. · Annals of the Rheumatic Diseases Open access 18 May 2013 607
3 Defining variant-resistant epitopes targeted by SARS-CoV-2 antibodies: A global consortium study Kathryn M. Hastie et al. · Science Open access 23 Sep 2021 343
4 Physicochemical characterization of Remsima® Soon Kwan Jung, Kyoung Hoon Lee, Jae Won Jeon et al. · mAbs Open access 5 Aug 2014 341
5 A therapeutic neutralizing antibody targeting receptor binding domain of SARS-CoV-2 spike protein Cheol-Min Kim et al. · Nature Communications Open access 12 Jan 2021 302
All 60 most cited papers, with filters and sorting

Which keywords describe research at Celltrion (South Korea)?

By fractional works in 2022-now, weighted toward what it does more of than the world: Monoclonal Antibodies, Biopharmaceuticals, Immunogenicity, Bioanalytical Methods, Biosimilars, Quality of Life, Cost-effectiveness Analysis and Health Utility Measures.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in 2022-now in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Monoclonal Antibodies10▲ 278×3 topics
  2. Biopharmaceuticals8▲ 382×2 topics
  3. Immunogenicity8▲ 457×2 topics
  4. Bioanalytical Methods7▲ 968×1 topic
  5. Biosimilars7▲ 968×1 topic
  6. Quality of Life5▲ 8.2×3 topics
  7. Cost-effectiveness Analysis4▲ 134×1 topic
  8. Health Utility Measures4▲ 134×1 topic
  9. Epidemiology4▲ 2.3×17 topics
  10. Inflammatory Bowel Disease3▲ 63×4 topics
  11. Drug Development Costs3▲ 282×1 topic
  12. Generic Drugs3▲ 282×1 topic
  13. Breast Cancer2▲ 24×2 topics
  14. Chemotherapy2▲ 8.4×7 topics
  15. Genetics2▲ 8.5×3 topics
  16. Pathogenesis2▲ 12×5 topics
  17. Therapeutic Antibodies2▲ 81×2 topics
  18. Crohn's Disease2▲ 68×1 topic
  19. Glycosylation2▲ 49×2 topics
  20. Ulcerative Colitis2▲ 114×1 topic
  21. Antibody Engineering2▲ 96×1 topic
  22. Fc Receptors2▲ 96×1 topic
  23. Monoclonal Antibody2▲ 80×2 topics
  24. Autoantibodies2▲ 18×3 topics
  25. HER22▲ 135×1 topic
  26. Inflammation2▲ 1.93×9 topics
  27. Trastuzumab2▲ 86×1 topic
  28. PET Imaging1▲ 20×3 topics
  29. Targeted Therapy1▲ 15×4 topics
  30. Cytokines1▲ 11×4 topics
  31. Cancer Treatment1▲ 12×2 topics
  32. Clinical Trials1▲ 4.5×4 topics
  33. Radioimmunotherapy1▲ 98×1 topic
  34. Radiopharmaceuticals1▲ 98×1 topic
  35. Rheumatoid Arthritis1▲ 30×2 topics
  36. Biological Therapy1▲ 46×1 topic
  37. Disease-Modifying Antirheumatic Drugs1▲ 53×1 topic
  38. Immune System1▲ 11×2 topics
  39. Regulatory T Cells1▲ 23×3 topics
  40. TGF-ß1▲ 17×2 topics

Which research topics does Celltrion (South Korea) publish most on?

By volume in 2022-now: Biosimilars and Bioanalytical Methods, Health Systems, Economic Evaluations, Quality of Life, Pharmaceutical Economics and Policy and Inflammatory Bowel Disease.

Biosimilars and Bioanaly…7Biosimilars and Bioanalytical Methods: 7 fractional worksHealth Systems, Economic…4Health Systems, Economic Evaluations, Quality of Life: 4 fractional worksPharmaceutical Economics…3Pharmaceutical Economics and Policy: 3 fractional worksInflammatory Bowel Disease: 2 fractional worksMonoclonal and Polyclonal Antibodies Research: 2 fractional worksHER2/EGFR in Cancer Rese…2HER2/EGFR in Cancer Research: 2 fractional worksRadiopharmaceutical Chemistry and Applications: 1 fractional worksRheumatoid Arthritis Research and Therapies: 1 fractional worksPsoriasis: Treatment and Pathogenesis: 1 fractional worksPharmaceutical studies and practices: 1 fractional works
ImmunologyEconomics and EconometricsGeneticsRadiology, Nuclear Medicine and Imaging3 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Biosimilars and Bioanalytical Methods Immunology 7 works
  2. 2 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 4 works
  3. 3 Pharmaceutical Economics and Policy Economics and Econometrics 3 works
  4. 4 Inflammatory Bowel Disease Genetics 2 works
  5. 5 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 2 works
  6. 6 HER2/EGFR in Cancer Research Oncology 2 works
  7. 7 Radiopharmaceutical Chemistry and Applications Radiology, Nuclear Medicine and Imaging 1 works
  8. 8 Rheumatoid Arthritis Research and Therapies Rheumatology 1 works
  9. 9 Psoriasis: Treatment and Pathogenesis Immunology 1 works
  10. 10 Pharmaceutical studies and practices Pediatrics, Perinatology and Child Health 1 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available53.1%not open46.9%

World: 40% of research is openly available.

with international co-authors41.7%domestic only58.3%

World: 18% is written across borders.

How has Celltrion (South Korea)'s research output changed?

Output in 2022-2025 was 0% lower than in 2018-2021.

still counting2010201520202025
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Celltrion (South Korea) as a percentage of every work published that year, 0.00014% in 2024.

still counting0.00010%0.00020%0.00030%Celltrion (South Korea)0.00020% in 202520102020

Fractional works of Celltrion (South Korea) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Incheon

All research institutions in Incheon

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Celltrion (South Korea). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.